These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 14511018)

  • 1. Response of cutaneous Rosai-Dorfman disease to topical and intralesional steroids.
    Satter EK; Graham BS; Steger JW
    Br J Dermatol; 2003 Sep; 149(3):672-4. PubMed ID: 14511018
    [No Abstract]   [Full Text] [Related]  

  • 2. Cutaneous Rosai-Dorfman disease.
    Gaul M; Chang T
    Cutis; 2019 Mar; 103(3):171-173. PubMed ID: 31039225
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intralesional methotrexate used in cutaneous Rosai-Dorfman disease.
    Nieto-Benito LM; Suárez-Fernández RM; Baniandrés-Rodríguez O
    Med Clin (Barc); 2020 Dec; 155(12):564-565. PubMed ID: 31759691
    [No Abstract]   [Full Text] [Related]  

  • 4. [Indolent firm reddish papules. Cutaneous Rosai-Dorfman disease].
    Bens G; Kerdraon R; De Kyvon JJ; Estève E
    Hautarzt; 2011 May; 62(5):384-7. PubMed ID: 21431448
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cutaneous Rosai-Dorfman disease: comprehensive review of cases reported in the medical literature since 1990 and presentation of an illustrative case.
    Frater JL; Maddox JS; Obadiah JM; Hurley MY
    J Cutan Med Surg; 2006; 10(6):281-90. PubMed ID: 17241598
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cutaneous Rosai-Dorfman disease of the face with a leonine appearance: successful response to dapsone.
    Lee YI; Kim SK; Oh SH; Kim DY
    Eur J Dermatol; 2018 Apr; 28(2):255-256. PubMed ID: 29400286
    [No Abstract]   [Full Text] [Related]  

  • 7. Cutaneous Rosai-Dorfman disease successfully treated with low-dose methotrexate.
    Sun NZ; Galvin J; Cooper KD
    JAMA Dermatol; 2014 Jul; 150(7):787-8. PubMed ID: 24789266
    [No Abstract]   [Full Text] [Related]  

  • 8. Low-dose weekly methotrexate used to treat cutaneous Rosai-Dorfman disease.
    Subash JJ; Kesty C; Kesty KR; Asgari M; Jorizzo J
    Clin Exp Dermatol; 2018 Oct; 43(7):849-851. PubMed ID: 29869440
    [No Abstract]   [Full Text] [Related]  

  • 9. Cutaneous Rosai-Dorfman Disease Located on the Breast: Rapid Effectiveness of Methotrexate After Failure of Topical Corticosteroids, Acitretin and Thalidomide.
    Nadal M; Kervarrec T; Machet MC; Petrella T; Machet L
    Acta Derm Venereol; 2015 Jul; 95(6):758-9. PubMed ID: 25632986
    [No Abstract]   [Full Text] [Related]  

  • 10. [Cutaneous Rosai-Dorfman syndrome. Successful therapy with intrralesional corticosteroids].
    Vandersee S; Röwert-Huber HJ; Wöhner S; Loddenkemper C; Beyer M; Humme D
    Hautarzt; 2014 Aug; 65(8):725-7. PubMed ID: 24831530
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Purely cutaneous Rosai-Dorfman disease].
    Plettenberg H; Artik S; Kuhn A; Megahed M; Ruzicka T; Kruse R
    Hautarzt; 2004 Oct; 55(10):969-71. PubMed ID: 15351867
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cutaneous Rosai-Dorfman disease.
    Ohnishi A; Yoshida Y; Yamamoto O
    J Dermatol; 2008 Sep; 35(9):604-5. PubMed ID: 18837709
    [No Abstract]   [Full Text] [Related]  

  • 13. Successful treatment of Rosai-Dorfman disease with low-dose oral thalidomide.
    Li X; Hong Y; An Q; Chen J; Wei H; Chen HD; Gao XH
    JAMA Dermatol; 2013 Aug; 149(8):992-3. PubMed ID: 23783880
    [No Abstract]   [Full Text] [Related]  

  • 14. Dome-shaped Papules on the Left Flank: A Quiz. Cutaneous Rosai-Dorfman Disease (sinus histiocytosis with massive lymphadenopathy.
    Roenneberg S; Hegyi I; Kempf W; Kerl K; Guenova E
    Acta Derm Venereol; 2018 Jan; 98(1):165-166. PubMed ID: 28795760
    [No Abstract]   [Full Text] [Related]  

  • 15. Extranodal Rosai-Dorfman disease with cutaneous, ophthalmic and laryngeal involvement: report of a case treated with isotretinoin.
    Chang LY; Kuo TT; Chan HL
    Int J Dermatol; 2002 Dec; 41(12):888-91. PubMed ID: 12492979
    [No Abstract]   [Full Text] [Related]  

  • 16. Intralesional steroid for orbital manifestations of Rosai-Dorfman disease.
    Petrushkin H; Salisbury J; O'Sullivan E
    Clin Exp Ophthalmol; 2015 Jul; 43(5):483-5. PubMed ID: 25488543
    [No Abstract]   [Full Text] [Related]  

  • 17. A case of histiocytic lymphophagocytic panniculitis (Rosai-Dorfman disease) with positive autoantibodies.
    Wang F; Chen X; Wu W; Wang Z; Han J
    J Dtsch Dermatol Ges; 2015 Apr; 13(4):334-6. PubMed ID: 25819246
    [No Abstract]   [Full Text] [Related]  

  • 18. Purely Cutaneous Rosai-Dorfman disease (CRDD) co-existed with capillary hemangioma successfully treated with intralesional corticosteroid.
    Asawabenjang W; Jerasutus S; Kattipathanapong P; Janjumratsang P; Tangjaturonrusamee C
    J Med Assoc Thai; 2013 Sep; 96(9):1239-41. PubMed ID: 24164002
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Atypical Primary Cutaneous Rosai Dorfman Disease: A Case Report.
    Kinio AE; Sawchuk MA; Pratt M
    J Cutan Med Surg; 2017; 21(5):460-463. PubMed ID: 28639453
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A case report demonstrating potential utility of topical imiquimod for cutaneous Rosai-Dorfman disease.
    Karadag AS; Tekin B; Hurdogan O; Dagdelen D; Dogan O; Buyukbabani N
    Dermatol Ther; 2019 Jan; 32(1):e12759. PubMed ID: 30288863
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.